Regeneron Results Soar on Eye-Treatment Sales

Regeneron Pharmaceuticals said profit and revenue soared in its third quarter, as sales of its key eye-disease treatment accelerated.

from WSJ.com: US Business http://ift.tt/1XOZWQB
via IFTTT